Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beth Israel Deaconess Medical Center
With
National Institute of Nursing Research (NINR)
This is study of aerosol treatment in a laboratory model of dyspnea in healthy subjects. This study is the first in a series of studies that will include investigation of a second dose in the laboratory and investigation of the treatment effect in hospitalized patients with refractory dyspnea. The outcome of this first study will determine the details of protocol for the succeeding studies.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy
You may not be if
Unstable heart or circulation disease
Stroke
Seizure disorder
Severe migraine headaches
Liver or kidney disease
Adrenal gland problem (Pheochromocytoma)
Nerve problems that may affect your breathing sensation
Brain cancer
Drug or alcohol problem
Systemic lupus erythematosis (SLE)
High levels of depression, panic disorder, or other significant mental health problems
Serious ongoing pain
Pregnant
Under 18 years old
Not Fluent in English
Clareo Health | Aerosol Inhalation Treatment for Dyspnea
